| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |